Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Calgary

$146,877.00

Promoting the arteriovenous fistula as hemodialysis access: expected benefits and unintended consequences

EF 2011-12

Résumé
Patients with non-functioning kidneys require access to their blood vessels to connect to dialysis machines. The arteriovenous fistula, one of the patient's own veins surgically connected to an artery, is considered the best access due to its lower risk of clotting and infection, as compared to other access types (grafts/catheters). Vascular access teams have been established in most dialysis programs in Canada to promote fistula use in as many patients as possible, including those planning to start dialysis. Nevertheless, fistula attempts in patients with arteries and veins of poor quality are often unsuccessful. In addition, fistula placement prior to dialysis is futile if patients eventually do not start dialysis because they die or their disease progresses more slowly than anticipated. Therefore, fistula promotion may fail to increase fistula use in some categories of patients, and may result in increased numbers of unnecessary surgeries in pre-dialysis patients at low risk of renal disease progression or at high risk of death. The present research will use data from the Alberta Kidney Disease Network from approximately 3000 subjects with severe kidney disease not yet on dialysis, about 1000 patients on hemodialysis and approximately 1500 patients who started dialysis between 1998 and 2011. Data will be captured and linked using different sources to study the impact of vascular access programs on both expected increased use of the fistula and unintended consequences of fistula promotion, including costs. This research will provide important information on the effect of programs promoting the fistula as hemodialysis access. This information will assist physicians in reviewing current practice to reduce vascular access complications and unnecessary surgeries, policy makers in identifying criteria for funding, and investigators in framing research questions to address with clinical trials.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
238470
Name
Ravani Pietro
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Health Services Evaluation & Interventions Research
Projecttitle
Promoting the arteriovenous fistula as hemodialysis access: expected benefits and unintended consequences
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$146,877
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Arteriovenous Fistula; Chronic Kidney Disease; Health Policy; Hemodialysis; Multidisciplinary Care; Vascular Access
Abstract
Patients with non-functioning kidneys require access to their blood vessels to connect to dialysis machines. The arteriovenous fistula, one of the patient's own veins surgically connected to an artery, is considered the best access due to its lower risk of clotting and infection, as compared to other access types (grafts/catheters). Vascular access teams have been established in most dialysis programs in Canada to promote fistula use in as many patients as possible, including those planning to start dialysis. Nevertheless, fistula attempts in patients with arteries and veins of poor quality are often unsuccessful. In addition, fistula placement prior to dialysis is futile if patients eventually do not start dialysis because they die or their disease progresses more slowly than anticipated. Therefore, fistula promotion may fail to increase fistula use in some categories of patients, and may result in increased numbers of unnecessary surgeries in pre-dialysis patients at low risk of renal disease progression or at high risk of death. The present research will use data from the Alberta Kidney Disease Network from approximately 3000 subjects with severe kidney disease not yet on dialysis, about 1000 patients on hemodialysis and approximately 1500 patients who started dialysis between 1998 and 2011. Data will be captured and linked using different sources to study the impact of vascular access programs on both expected increased use of the fistula and unintended consequences of fistula promotion, including costs. This research will provide important information on the effect of programs promoting the fistula as hemodialysis access. This information will assist physicians in reviewing current practice to reduce vascular access complications and unnecessary surgeries, policy makers in identifying criteria for funding, and investigators in framing research questions to address with clinical trials.
Competitiondate
201109
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Ravani, Pietro
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $146,877~ $0~